Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: EU approves diabetes pill Qtrilmet

(CercleFinance.com) - The European Commission has approved AstraZeneca's Qtrilmet tablets for improving glycaemic control in adults with type-2 diabetes, the drugmaker said on Friday.


The once-daily oral drug was already approved in the US in May this year.

Copyright (c) 2019 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.